Literature DB >> 9761417

Enhancement of immobility in mouse forced swimming test by treatment with human interferon.

M Makino1, Y Kitano, M Hirohashi, K Takasuna.   

Abstract

We investigated the depression induced by human interferons using the forced swimming test in mice. Intravenous (i.v.) administration of interferon-alpha s (natural interferon-alpha, recombinant interferon-alpha-2a and recombinant interferon-alpha-2b, 600-60000 IU/kg) increased the immobility time in the forced swimming test in a dose-dependent manner, but natural interferon-beta and recombinant interferon-gamma-1a did not affect the immobility time. The increase in the immobility time induced by recombinant interferon-alpha-2b peaked at 15 min after dosing. Administration of recombinant interferon-alpha-2b (6000 IU/kg, i.v.) once daily for 7 consecutive days increased the immobility time, but natural interferon-beta and recombinant interferon-gamma-la did not. Recombinant interferon-alpha-2b in combination with the anti-depressants imipramine (10 mg/kg, i.p.) and mianserin (20 mg/kg, i.p.) did not increase the immobility time. These results suggest that interferon-alpha has a greater potential for inducing depression than interferon-beta and -gamma, and that anti-depressants are effective against interferon-alpha-induced depression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9761417     DOI: 10.1016/s0014-2999(98)00474-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

1.  Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression.

Authors:  Jennifer C Felger; Oyetunde Alagbe; Fang Hu; Deborah Mook; Amanda A Freeman; Mar M Sanchez; Ned H Kalin; Emiliangelo Ratti; Charles B Nemeroff; Andrew H Miller
Journal:  Biol Psychiatry       Date:  2007-08-02       Impact factor: 13.382

Review 2.  Inflammatory cytokine-associated depression.

Authors:  Francis E Lotrich
Journal:  Brain Res       Date:  2014-07-05       Impact factor: 3.252

3.  Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test.

Authors:  M Makino; Y Kitano; C Komiyama; M Hirohashi; K Takasuna
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

4.  Behavioral evaluation of transgenic mice with CNS expression of IFN-alpha by elevated plus-maze and Porsolt swim test.

Authors:  Hua Zhang; Zhanzhuang Tian; Jianping Wang
Journal:  Neurosci Lett       Date:  2010-06-04       Impact factor: 3.046

5.  Decreased immobility in swimming test by homologous interferon-alpha in mice accompanied with increased cerebral tryptophan level and serotonin turnover.

Authors:  Jianping Wang; Adrian J Dunn; Amanda J Roberts; Hua Zhang
Journal:  Neurosci Lett       Date:  2009-01-24       Impact factor: 3.046

6.  Development of a murine animal model of depression for repeated dosing with human interferon alpha.

Authors:  Nagesh Koregala Siddegowda; N Sanjay Kumar Rao; Chittaranjan Andrade
Journal:  Indian J Psychiatry       Date:  2011-07       Impact factor: 1.759

7.  Mechanisms for interferon-α-induced depression and neural stem cell dysfunction.

Authors:  Lian-Shun Zheng; Seiji Hitoshi; Naoko Kaneko; Keizo Takao; Tsuyoshi Miyakawa; Yasuhito Tanaka; Hongjing Xia; Ulrich Kalinke; Koutaro Kudo; Shigenobu Kanba; Kazuhiro Ikenaka; Kazunobu Sawamoto
Journal:  Stem Cell Reports       Date:  2014-06-26       Impact factor: 7.765

8.  Effects of interferon-alpha on hippocampal neurogenesis and behavior in common marmosets.

Authors:  Naoko Kaneko; Sayuri Nakamura; Kazunobu Sawamoto
Journal:  Mol Brain       Date:  2020-06-26       Impact factor: 4.041

9.  Interferon-α exacerbates neuropsychiatric phenotypes in lupus-prone mice.

Authors:  Jing Zeng; Xinyu Meng; Ping Zhou; Zhihua Yin; Qinglian Xie; Hong Zou; Nan Shen; Zhizhong Ye; Yuanjia Tang
Journal:  Arthritis Res Ther       Date:  2019-09-03       Impact factor: 5.156

Review 10.  The renin-angiotensin system: a possible new target for depression.

Authors:  João Vian; Círia Pereira; Victor Chavarria; Cristiano Köhler; Brendon Stubbs; João Quevedo; Sung-Wan Kim; André F Carvalho; Michael Berk; Brisa S Fernandes
Journal:  BMC Med       Date:  2017-08-01       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.